Corylin



Compound IDCDAMM00381
Common nameCorylin
IUPAC name3-(2,2-dimethylchromen-6-yl)-7-hydroxychromen-4-one
Molecular formulaC20H16O4

Experimental data

Retention time7.209
Adduct[M+H]+
Actual mz321.115
Theoretical mz321.112
Error8.61
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.12

Identifiers and class information

Inchi keyPWAACAMQKVIVPZ-UHFFFAOYSA-N
SmilesO=C1C(=COC2=CC(O)=CC=C21)C=3C=CC=4OC(C=CC4C3)(C)C
SuperclassPhenylpropanoids and polyketides
ClassIsoflavonoids

Pharmacokinetic properties

Number of descriptor values(#stars)0
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)2
Number of reactive functional groups (#rtvFG)0
Predicted central nervous system activity (CNS)0
Molecular weight (mol_MW)320.344
Computed dipole moment(dipole)2.687
Total solvent accessible surface area (SASA)587.954
Hydrophobic component of SASA (FOSA)153.09
Hydrophilic component of SASA (FISA)95.141
Pie component of the SASA (PISA)339.723
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1017.34
Number of hydrogen bond donors (donorHB)1
Number of hydrogen bond acceptors (accptHB)4
Free energy of solvation of dipole (dip^2/V)0.0070948
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0068033
Globularity descriptor (glob)0.832017
Predicted polarizability in cubic angstroms (QPpolrz)36.52
Predicted hexadecane/gas partition coefficient (QPlogPC16)10.919
Predicted octanol/gas partition coefficient (QPlogPoct)15.717
Predicted water/gas partition coefficient (QPlogPw)9.056
Predicted octanol/water partition coefficient (QPlogPo/w)3.719
Predicted aqueous solubility (QPlogS)-5.217
Conformation-independent predicted aqueous solubility (CIQPlogS)-5.255
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-5.87
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)1240.74
Predicted brain/blood partition coefficient (QPlogBB)-0.473
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)624.607
Predicted skin permeability, log Kp (QPlogKp)-1.884
PM3 calculated ionization potential (IP(ev))8.762
PM3 calculated electron affinity (EA(eV))0.55
Number of likely metabolic reactions (#metab)1
Prediction of binding to human serum albumin (QPlogKhsa)0.527
Predicted qualitative human oral absorption (HumanOralAbsorption)3
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)100
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)65.111
Number of nitrogen and oxygen atoms (#NandO)4
Number of violations of Lipinski’s rule of five (RuleOfFive)0
Number of violations of Jorgensen’s rule of three (RuleOfThree)0

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
O43570CA12Carbonic anhydrase XIIT16987SwissTargetPrediction
P43166CA7Carbonic anhydrase VIIT37541SwissTargetPrediction
P11926ODC1Ornithine decarboxylaseT60366SEA
Q92731ESR2Estrogen receptor betaT80896SEA
P18031PTPN1Protein-tyrosine phosphatase 1BT16347SwissTargetPrediction
O95718ESRRBEstrogen-related receptor betaT42025SEA
P16050ALOX15Arachidonate 15-lipoxygenaseT16042SEA
P18054ALOX12Arachidonate 12-lipoxygenaseT35527SEA
Q08499PDE4DPhosphodiesterase 4DT02001SwissTargetPrediction
P60568IL2Interleukin-2T61698SwissTargetPrediction and SEA
P30837ALDH1B1Acetaldehyde dehydrogenaseT99641SwissTargetPrediction and SEA
P14679TYRTyrosinaseT97035SEA
P47989XDHXanthine dehydrogenaseT40954SEA
Q16678CYP1B1Cytochrome P450 1B1T92521SEA
P16152CBR1Carbonyl reductase [NADPH] 1T70518SEA
Q13332PTPRSReceptor-type tyrosine-protein phosphatase ST10147SEA
Q9NZ08ERAP1Endoplasmic reticulum aminopeptidase 1T72849SEA
P30837ALDH1B1Acetaldehyde dehydrogenaseT99641SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T16987DI0046Bacterial infection[ICD-11: 1A00-1C4Z]O43570CA12
T16987DI0372Seborrhoeic dermatitis[ICD-11: EA81]O43570CA12
T60366DI0020African trypanosomiasis[ICD-11: 1F51]P11926ODC1
T80896DI0062Breast cancer[ICD-11: 2C60-2C6Y]Q92731ESR2
T80896DI0108Cushing syndrome[ICD-11: 5A70]Q92731ESR2
T80896DI0254Menopausal disorder[ICD-11: GA30]Q92731ESR2
T80896DI0432Vasomotor/allergic rhinitis[ICD-11: CA08]Q92731ESR2
T16347DI0009Acute diabete complication[ICD-11: 5A2Y]P18031PTPN1
T16347DI0062Breast cancer[ICD-11: 2C60-2C6Y]P18031PTPN1
T16347DI0308Obesity[ICD-11: 5B80-5B81]P18031PTPN1
T16347DI0417Type 2 diabetes mellitus[ICD-11: 5A11]P18031PTPN1
T02001DI0411Tonus and reflex abnormality[ICD-11: MB47]Q08499PDE4D
T61698DI0275Multiple sclerosis[ICD-11: 8A40]P60568IL2
T61698DI0361Renal cell carcinoma[ICD-11: 2C90]P60568IL2
T99641DI0396Substance abuse[ICD-11: 6C40]P30837ALDH1B1
T97035DI0007Acquired hypermelanosis[ICD-11: ED60]P14679TYR
T97035DI0008Acquired hypomelanotic disorder[ICD-11: ED63]P14679TYR
T40954DI0206Inborn purine/pyrimidine/nucleotide metabolism error[ICD-11: 5C55]P47989XDH
T40954DI0266Mineral deficiency[ICD-11: 5B5K]P47989XDH
T70518DI0037Asthma[ICD-11: CA23]P16152CBR1
T10147DI0057Bone paget disease[ICD-11: FB85]Q13332PTPRS
T99641DI0396Substance abuse[ICD-11: 6C40]P30837ALDH1B1

Copyright © 2025